3Cherpelis BS,Glass LF,Ladd S,et al.Mobs surgery for melanoma in situ:how we d0 it[J].J Drugs Dermami,2010,9(7):786-788.
4Sroa N,Campbell S,Ravitskiy L Immunohistochemistry in mohs micrographic surgery:a review of the literature[J].J Clin Aesthct Dermatol.2009,2(7):37-42.
5Stranahan DR,Cherpelis BS,Fenske NA,et al.Advances in immunostains used in Mohs surgery[J].J Drugs Dermatol,20101;9(7):760-763.
6Blá zquez-Sá nchez N,de Troya-Marti n M,Frieyro-Elicegui M,et al.Cost analysis of Mobs micrographic surgery in high-risk facial basal cell carcinoma[J].Actas Dormosifiliogr,2010,101(7):622-628.
7Guardiano RA,Grande DJ.A direct comparison of visual inspection,curettage,and epiluminescence microscopy in determining tumor extent before the initial margins are determined for Mohs micrographic surgery[J].Dermatol Surg,2010,36(8):1240-1244.
8Morton CA,Brown SB,Collins S,et al. Guidelines for topical photodynamic therapy:Report of a workshop of the British Photodematology Group[J].Br J Dermatol,2002,146(4):552-567.
9Dougherty TJ.Photosensitizers:therapy and detection of malignant tumors[J].Photochem Phutobiol, 1987,45: 879-889.
10Choudhary S,Nouri K,Elsaie ML.Photodynamic therapy in dermatology: a review[J].Lasers Meal Sci,2009,24:(6):971-800.
